Animal Models of Uveal Melanoma: Methods, Applicability, and Limitations
暂无分享,去创建一个
[1] F. Holz,et al. Overexpression of hepatocyte growth factor and an oncogenic CDK4 variant in mice alters corneal stroma morphology but does not lead to spontaneous ocular melanoma. , 2016, Melanoma research.
[2] Syed Junaid Hassan,et al. Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma , 2016, Oncotarget.
[3] F. Holz,et al. Intravitreally Injected HCmel12 Melanoma Cells Serve as a Mouse Model of Tumor Biology of Intraocular Melanoma , 2016, Current eye research.
[4] D. Hu,et al. Effects of Zeaxanthin on Growth and Invasion of Human Uveal Melanoma in Nude Mouse Model , 2015, Journal of ophthalmology.
[5] J. Abastado,et al. Lymphadenectomy promotes tumor growth and cancer cell dissemination in the spontaneous RET mouse model of human uveal melanoma , 2015, Oncotarget.
[6] Arati Sharma,et al. Current State of Animal (Mouse) Modeling in Melanoma Research , 2015, Cancer growth and metastasis.
[7] P. Queirolo,et al. Potential Role of Soluble c-Met as a New Candidate Biomarker of Metastatic Uveal Melanoma. , 2015, JAMA ophthalmology.
[8] J. Huang,et al. Oncogenic G Protein GNAQ Induces Uveal Melanoma and Intravasation in Mice. , 2015, Cancer research.
[9] S. Chahory,et al. A case of primary choroidal malignant melanoma in a cat. , 2015, Veterinary ophthalmology.
[10] C. Shields,et al. American Joint Committee on Cancer Classification of Uveal Melanoma (Anatomic Stage) Predicts Prognosis in 7,731 Patients: The 2013 Zimmerman Lecture. , 2015, Ophthalmology.
[11] Xiaoping Hu,et al. Protein MRI contrast agent with unprecedented metal selectivity and sensitivity for liver cancer imaging , 2015, Proceedings of the National Academy of Sciences.
[12] M. Hendrix,et al. Genetic analysis of the ‘uveal melanoma’ C918 cell line reveals atypical BRAF and common KRAS mutations and single tandem repeat profile identical to the cutaneous melanoma C8161 cell line , 2015, Pigment cell & melanoma research.
[13] Matthew W. Wilson,et al. International Validation of the American Joint Committee on Cancer's 7th Edition Classification of Uveal Melanoma. , 2015, JAMA ophthalmology.
[14] P. Davis,et al. Low thyroid hormone levels improve survival in murine model for ocular melanoma , 2015, Oncotarget.
[15] J. Abastado,et al. Macrophage depletion reduces postsurgical tumor recurrence and metastatic growth in a spontaneous murine model of melanoma , 2015, Oncotarget.
[16] A. Nicolas,et al. Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target , 2014, Molecular oncology.
[17] A. Bosserhoff,et al. Tg(Grm1) transgenic mice: a murine model that mimics spontaneous uveal melanoma in humans? , 2014, Experimental eye research.
[18] S. Thorne,et al. Splenectomy Promotes Indirect Elimination of Intraocular Tumors by CD8+ T Cells That Is Associated with IFNγ- and Fas/FasL-Dependent Activation of Intratumoral Macrophages , 2014, Cancer Immunology Research.
[19] A. Jochemsen,et al. Modeling of human uveal melanoma in zebrafish xenograft embryos. , 2014, Investigative ophthalmology & visual science.
[20] Kang Zhang,et al. Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP. , 2014, Cancer cell.
[21] B. Damato,et al. Chick embryo model systems to study uveal melanoma metastasis , 2014 .
[22] M. Ghert,et al. Lost in translation: animal models and clinical trials in cancer treatment. , 2014, American journal of translational research.
[23] L. Desjardins,et al. Targeting Bcl-2/Bcl-XL Induces Antitumor Activity in Uveal Melanoma Patient-Derived Xenografts , 2014, PloS one.
[24] Manuel Hidalgo,et al. Patient-derived xenograft models: an emerging platform for translational cancer research. , 2014, Cancer discovery.
[25] Gary K. Schwartz,et al. Crizotinib, a c-Met Inhibitor, Prevents Metastasis in a Metastatic Uveal Melanoma Model , 2013, Molecular Cancer Therapeutics.
[26] G. Hannon,et al. Patient-derived tumor xenografts: transforming clinical samples into mouse models. , 2013, Cancer research.
[27] A. Bowcock,et al. BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma , 2013, BMC Cancer.
[28] H. Grossniklaus,et al. Host pigment epithelium-derived factor (PEDF) prevents progression of liver metastasis in a mouse model of uveal melanoma , 2013, Clinical & Experimental Metastasis.
[29] S. J. Kang,et al. In vivo high-frequency contrast-enhanced ultrasonography of choroidal melanoma in rabbits: imaging features and histopathologic correlations , 2013, British Journal of Ophthalmology.
[30] D. Schadendorf,et al. Conjunctival Melanomas Harbor BRAF and NRAS Mutations and Copy Number Changes Similar to Cutaneous and Mucosal Melanomas , 2013, Clinical Cancer Research.
[31] M. Jager,et al. Inflammation in uveal melanoma , 2013, Eye.
[32] H. Grossniklaus,et al. Bevacizumab and intraocular tumors: an intriguing paradox , 2012, Molecular vision.
[33] N. Sharpless,et al. Genetically engineered cancer models, but not xenografts, faithfully predict anticancer drug exposure in melanoma tumors. , 2012, The oncologist.
[34] H. Kluger,et al. Driver Mutations in Melanoma: Lessons Learned From Bench-to-Bedside Studies , 2012, Current Oncology Reports.
[35] R. Braun,et al. Modeling human choroidal melanoma xenograft growth in immunocompromised rodents to assess treatment efficacy. , 2012, Investigative ophthalmology & visual science.
[36] J. Verne,et al. Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe. , 2012, European journal of cancer.
[37] M J Jager,et al. Synergistic growth inhibition based on small-molecule p53 activation as treatment for intraocular melanoma , 2012, Oncogene.
[38] S. Woodman,et al. Genetic and molecular characterization of uveal melanoma cell lines , 2012, Pigment cell & melanoma research.
[39] Arun D. Singh,et al. Uveal melanoma: trends in incidence, treatment, and survival. , 2011, Ophthalmology.
[40] Peter W. Chen,et al. NKT cell exacerbation of liver metastases arising from melanomas transplanted into either the eyes or spleens of mice. , 2011, Investigative ophthalmology & visual science.
[41] S. J. Kang,et al. In vivo high-frequency, contrast-enhanced ultrasonography of uveal melanoma in mice: imaging features and histopathologic correlations. , 2011, Investigative ophthalmology & visual science.
[42] J. O'Brien,et al. Mutations in GNA11 in uveal melanoma. , 2010, The New England journal of medicine.
[43] M. Planellas,et al. Unusual presentation of a metastatic uveal melanoma in a cat. , 2010, Veterinary ophthalmology.
[44] E. Jordanova,et al. In Aged Mice, Outgrowth of Intraocular Melanoma Depends on Proangiogenic M2-Type Macrophages , 2010, The Journal of Immunology.
[45] J. Abastado,et al. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. , 2010, The Journal of clinical investigation.
[46] H. Grossniklaus,et al. Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma. , 2010, Investigative ophthalmology & visual science.
[47] E. Barillot,et al. Establishment and Characterization of a Panel of Human Uveal Melanoma Xenografts Derived from Primary and/or Metastatic Tumors , 2010, Clinical Cancer Research.
[48] M. D’Incalci,et al. Contemporary pre-clinical development of anticancer agents--what are the optimal preclinical models? , 2009, European journal of cancer.
[49] J. Augsburger,et al. Effectiveness of treatments for metastatic uveal melanoma. , 2009, American journal of ophthalmology.
[50] J. Marshall,et al. The effect of blue light exposure in an ocular melanoma animal model , 2009, Journal of experimental & clinical cancer research : CR.
[51] Baocun Sun,et al. A pilot study of vasculogenic mimicry immunohistochemical expression in intraocular melanoma model. , 2009, Oncology reports.
[52] E. Simpson,et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue nevi , 2008, Nature.
[53] R. Folberg,et al. Authenticating Cell Lines in Ophthalmic Research Laboratories N E W D E V E L O P M E N T S , 2022 .
[54] A. Richmond,et al. Mouse xenograft models vs GEM models for human cancer therapeutics , 2008, Disease Models & Mechanisms.
[55] H. Grossniklaus,et al. In-vivo xenograft murine human uveal melanoma model develops hepatic micrometastases , 2008, Melanoma research.
[56] J. Niederkorn,et al. Differential expression of chemokine receptors on uveal melanoma cells and their metastases. , 2008, Investigative ophthalmology & visual science.
[57] A. Biggeri,et al. Incidence of uveal melanoma in Europe. , 2007, Ophthalmology.
[58] W. Tolleson,et al. Two Cases of Uveal Amelanotic Melanoma in Transgenic Tyr-HRAS+ Ink4a/Arf Heterozygous Mice , 2007, Toxicologic pathology.
[59] J. Marshall,et al. The use of a cyclooxygenase-2 inhibitor (Nepafenac) in an ocular and metastatic animal model of uveal melanoma. , 2007, Carcinogenesis.
[60] R. Folberg,et al. Modeling the behavior of uveal melanoma in the liver. , 2007, Investigative ophthalmology & visual science.
[61] A. Nantel,et al. Transcriptional profiling of human uveal melanoma from cell lines to intraocular tumors to metastasis , 2007, Clinical & Experimental Metastasis.
[62] D. Redelmeier,et al. Translation of research evidence from animals to humans. , 2006, JAMA.
[63] M. Barbacid,et al. Rapid growth of invasive metastatic melanoma in carcinogen-treated hepatocyte growth factor/scatter factor-transgenic mice carrying an oncogenic CDK4 mutation. , 2006, The American journal of pathology.
[64] Dae-Yong Kim,et al. Malignant ocular melanoma in a dog , 2006, Journal of veterinary science.
[65] H. Grossniklaus,et al. Combined Immunologic and Anti-Angiogenic Therapy Reduces Hepatic Micrometastases in a Murine Ocular Melanoma Model , 2006, Current eye research.
[66] J. Marshall,et al. Characterization of ocular and metastatic uveal melanoma in an animal model. , 2005, Investigative ophthalmology & visual science.
[67] J. Earle,et al. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. , 2005, Archives of ophthalmology.
[68] L. Chin,et al. Spontaneous uveal amelanotic melanoma in transgenic Tyr-RAS+ Ink4a/Arf-/- mice. , 2005, Archives of ophthalmology.
[69] N. Schalij-Delfos,et al. Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis. , 2005, Investigative ophthalmology & visual science.
[70] Ahmedin Jemal,et al. Incidence of noncutaneous melanomas in the U.S. , 2005, Cancer.
[71] A. Almaraz,et al. Efficacy of five human melanocytic cell lines in experimental rabbit choroidal melanoma , 2005, Melanoma research.
[72] M. Lindstrom,et al. Effectiveness of 1alpha-hydroxyvitamin D2 in inhibiting tumor growth in a murine transgenic pigmented ocular tumor model. , 2004, Archives of ophthalmology.
[73] L. Kèlland,et al. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development. , 2004, European journal of cancer.
[74] T. Kivelä,et al. Very long-term prognosis of patients with malignant uveal melanoma. , 2003, Investigative ophthalmology & visual science.
[75] S. Heegaard,et al. Establishment and characterization of human uveal malignant melanoma xenografts in nude mice , 2003, Melanoma research.
[76] R. Folberg,et al. An orthotopic model for human uveal melanoma in SCID mice. , 2002, Microvascular research.
[77] K. Kwong,et al. MRI of Blood Volume and Cellular Uptake of Superparamagnetic Iron in an Animal Model of Choroidal Melanoma , 2002, Ophthalmic Research.
[78] A. Miodoński,et al. Angiomorphology of the pigmented Bomirski melanoma growing in hamster eye. , 2001, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.
[79] N. Moins,et al. Establishment of IPC 227 cells as human xenografts in rabbits: a model of uveal melanoma , 2000, Melanoma research.
[80] Y. Diebold,et al. Uveal melanoma model with metastasis in rabbits: effects of different doses of cyclosporine A. , 2000, Current eye research.
[81] H. Grossniklaus,et al. Animal models of uveal melanoma. , 2000, Melanoma research.
[82] H. Grossniklaus,et al. A new technique for implantation of tissue culture melanoma cells in a murine model of metastatic ocular melanoma , 2000, Melanoma research.
[83] J. Tutor,et al. Uveal melanoma model with metastasis in rabbits: Effects of different doses of cyclosporine A , 2000 .
[84] R. Folberg,et al. Evaluation of the human choroidal melanoma rabbit model for studying microcirculation patterns with confocal ICG and histology. , 1999, Experimental eye research.
[85] I H Wallow,et al. Transgenic mice with pigmented intraocular tumors: tissue of origin and treatment. , 1998, Investigative ophthalmology & visual science.
[86] Wei Liu,et al. Transgenic mouse model for skin malignant melanoma , 1998, Oncogene.
[87] H. Grossniklaus,et al. Pigmented uveal tumours in a transgenic mouse model , 1998, The British journal of ophthalmology.
[88] J. Niederkorn,et al. Antibody-Mediated Cytolysis of Epidermal Growth Factor Receptor — Positive Human Uveal Melanoma Cells , 2005 .
[89] R. Gerard,et al. Inhibition of metastasis of intraocular melanomas by adenovirus-mediated gene transfer of plasminogen activator inhibitor type 1 (PAI-1) in an athymic mouse model. , 1997, Blood.
[90] T. Luider,et al. Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model. , 1996, Investigative ophthalmology & visual science.
[91] M. Meyer,et al. Clinicopathologic spectrum of primary uveal melanocytic lesions in an animal model. , 1992, Ophthalmology.
[92] C. Shields,et al. Management of posterior uveal melanoma. , 1991, Survey of ophthalmology.
[93] J. Render,et al. Anterior uveal melanoma, with secondary keratitis, cataract, and glaucoma, in a horse. , 1991, Journal of the American Veterinary Medical Association.
[94] G. Sanborn,et al. Mouse model of brachytherapy in consort with enucleation for treatment of malignant intraocular melanoma. , 1990, Archives of ophthalmology.
[95] J. Niederkorn,et al. Immunologic evaluation of spontaneous regression of an intraocular murine melanoma. , 1990, Investigative ophthalmology & visual science.
[96] J. Schuh. Congenital intraocular melanoma in a calf. , 1989, Journal of comparative pathology.
[97] A. Slominski,et al. The natural history of a family of transplantable melanomas in hamsters , 1988, Cancer and Metastasis Reviews.
[98] W. Mieler,et al. A new technique for subchoroidal implantation of experimental malignant melanoma. , 1988, Investigative ophthalmology & visual science.
[99] R. Peiffer,et al. Morphology and Behavior of Primary Ocular Melanomas in 91 Dogs , 1986, Veterinary pathology.
[100] Jørgensen Jb,et al. Malignant melanoma of the uvea in the dog. , 1986 .
[101] J. Niederkorn. Enucleation in consort with immunologic impairment promotes metastasis of intraocular melanomas in mice. , 1984, Investigative ophthalmology & visual science.
[102] D. Albert,et al. Feline uveal melanoma model induced with feline sarcoma virus. , 1981, Investigative ophthalmology & visual science.
[103] G. Nicolson,et al. Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines. , 1976, Journal of the National Cancer Institute.
[104] D. Krohn,et al. Subchoroidal transplantation of experimental malignant melanoma. , 1970, American journal of ophthalmology.
[105] P. Henkind,et al. Intra-ocular malignant melanoma in domestic cats. , 1969, Transactions of the ophthalmological societies of the United Kingdom.
[106] D. Albert,et al. In vitro neoplastic transformation of uveal and retinal tissue by oncogenic DNA viruses. , 1968, Investigative ophthalmology.
[107] H. Greene,et al. The growth and metastasis of amelanotic melanomas in heterologous hosts. , 1966, Cancer research.
[108] F. Fraunfelder,et al. Experimental intraocular malignant melanoma in the Syrian Golden hamster. , 1961, American journal of ophthalmology.
[109] T. Manser,et al. Establishment and Characterization of Orthotopic Mouse Models for Human Uveal Melanoma Hepatic Colonization. , 2016, The American journal of pathology.
[110] H. Grossniklaus,et al. Constitutive overexpression of pigment epithelium-derived factor inhibition of ocular melanoma growth and metastasis. , 2010, Investigative ophthalmology & visual science.
[111] G. Barsh,et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi , 2010 .
[112] N. Rao,et al. Heterotransplantation of human uveal melanoma , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.
[113] R. Scully,et al. Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15. , 2001, Archives of ophthalmology.
[114] H. Grossniklaus,et al. B16LS9 melanoma cells spread to the liver from the murine ocular posterior compartment (PC). , 1999, Current eye research.
[115] H. Grossniklaus,et al. Murine model of anterior and posterior ocular melanoma. , 1995, Current eye research.
[116] E. Gragoudas,et al. ESTABLISHMENT OF PIGMENTED CHOROIDAL MELANOMAS IN A RABBIT MODEL , 1994, Retina.
[117] E. Mayhew,et al. Effect of anti-ganglioside antibodies on the metastatic spread of intraocular melanomas in a nude mouse model of human uveal melanoma. , 1993, Current eye research.
[118] K. Regan,et al. Intraocular melanoma with multiple metastases in a cat. , 1988, Journal of the American Veterinary Medical Association.
[119] J. Jorgensen,et al. Malignant melanoma of the uvea in the dog. , 1986, Nordisk veterinaermedicin.